Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma
NCT ID: NCT05478889
Last Updated: 2022-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
478 participants
OBSERVATIONAL
2021-11-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy
NCT01931449
Minimally Invasive Pancreatico-duodenectomy
NCT02807701
Preoperative Biliary Drainage in Malignant Biliary Obstruction
NCT04847297
Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy
NCT04662346
Textbook and Survival Outcomes of MIPD in South Korea
NCT05975710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Minimally invasive pancreatoduodenectomy
Whipple or pylorus preserving pancreatoduodenectomy following minimally invasive approach (laparoscopic or robotic). Hybrid (hand assisted) precedures will be included in the minimally invasive cohort.
Minimally invasive pancreatoduodenectomy
Whipple's procedure using minimally invasive (laparoscopic/robotic) techniques
Open pancreatoduodenectomy
Whipple or pylorus preserving pancreatoduodenectomy following open (laparotomy) approach.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minimally invasive pancreatoduodenectomy
Whipple's procedure using minimally invasive (laparoscopic/robotic) techniques
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective upfront curative MIPD or OPD between January 1, 2010 and December 31, 2021
* Pathological confirmed dCCA
Exclusion Criteria
* Palliative surgical procedures
* Intraoperative detection of unresectable disease (i.e., metastasis or locally advanced disease)
* Post-operative pathological diagnosis was other than dCCA (e.g., neuroendocrine tumor, polyposis adenoma)
* R2 positive resection margin
* Pregnancy
* Missing primary endpoints
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Poliambulanza Istituto Ospedaliero
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moh'd Abu Hilal, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Poliambulanza
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Poliambulanza Istituto Ospedaliero
Brescia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FPoliambulanza
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.